MCRB Competitors & Alternatives
Compare Seres Therapeutics Inc with similar stocks in the same industry
Biotechnology
MCRB
Main Stock$2.24
Tradestie Score
53
Market Cap
$179.47M
Revenue Growth
-0.9%
Analyst Upside
+660.6%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.80
|
$154.27M | - | 45 | Compare |
|
FATE
Fate Therapeutics, Inc.
|
$2.07
|
$144.16M | - | 58 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.80
|
$133.50M | - | 67 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.59
|
$114.01M | - | 67 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$23.37
|
$110.20M | - | 71 | Compare |
|
MGNX
MacroGenics, Inc.
|
$3.60
|
$107.45M | - | 67 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.99
|
$84.52M | - | 39 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.38
|
$67.94M | - | 63 | Compare |
|
KPTI
Karyopharm Therapeutics Inc.
|
$0.46
|
$53.85M | - | 43 | Compare |
|
SYRS
SYRS
|
- | - | - | - | Compare |
More MCRB Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry